• English
  • Français
Taro a SUN PHARMA Company
Menu
  • HOME
  • Worldwide sites
    • International Flag Taro Corporate
    • USA Flag Taro U.S.A
    • Canada Flag Taro Canada
    • Israel Flag Taro Israel
    • International Flag Taro International
    • Sun Pharma logo Sun Pharma
    • Sun USA Sun Pharmaceutical USA
    • Sun pharma Europe Sun Pharmaceutical Europe
    • Chattem Flag Chattem Chemicals Inc.
  • English
  • Français
  • Products
      • 4368Taro
      • 6356TaroPharma
  • Search
      • Search form

Customer Service
  • Report Adverse Event
Health Products
WCAG 2.0
Print

RAN-CEFPROZIL (Dec)

Wed, 12/18/2019 - 10:33 — Taroadmin

RAN-CEFPROZIL ORAL SUSPENSION is transitioning to TARO-CEFPROZIL ORAL SUSPENSION; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs and formulations will remain the same, only the prefix will change. click here

Release Date: 
Thursday, December 12, 2019
  • Log in to post comments
Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement
  • Home
  • About Us
    • About Taro Canada
    • Company History
    • Company Mission
    • Generic Drugs
    • Worldwide Sites
    • FAQ about Generics
  • Products
    • Taro
    • TaroPharma
  • Customer Service
    • Customer Service
    • Contact Us
    • Report Adverse Event
  • Investors
  • Careers
    • Overview
    • Job Postings
    • Accessibility
    • Total Rewards
    • Location
  • Worldwide Sites
    • Taro U.S.A
    • Taro Canada
    • Taro Israel
    • Taro International
    • Sun Pharma
    • Sun Pharmaceutical USA
    • Sun Pharmaceutical Europe
    • Chattem Chemicals Inc.
  • Contact Us
  • Sitemap